Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will
- Written by Efthimios Parasidis, Professor of Law and Public Health, The Ohio State University
A patient receives a shot in a clinical trial for a COVID-19 vaccine.AP Photo/Ted S. WarrenAmericans are increasingly concerned that regulators and manufacturers will rush a vaccine to market without an adequate review.
That prompted nine vaccine front-runners, including Pfizer and Merck, to promise to abide by clinical and ethical standards in an...